For research use only. Not for therapeutic Use.
Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.
| Catalog Number | I047444 |
| Purity | ≥95% |
